Aktiesnakken — Januar 2011
-
hvis arzerra bliver 5bn. Så tjener genmab 5 milliarder i royalties
-
ahh ok
-
så er jeg mere med
-
5bn ligger nok fremme i 2016-17
-
Genmab er ikke dyr ihvertfald Pro
-
ja....men vi er også nogle oddere
-
Ja solsen... har du noget statistik på hvad J-code kan betyde?
-
jeg synes det er svært at vurdere. Det betyder noget for forsikringen ikke?
-
og hvor hurtigt klinikkerne kan få deres penge?
-
Ja David Eatwell har også nævnt det et par gange
-
ahhh, now we are talking
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind